CTSA Postdoctoral T32 at the University of Michigan
Project Number1T32TR004764-01
Contact PI/Project LeaderHARTE, STEVEN EDWARD Other PIs
Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
Project Summary
The Michigan Institute for Clinical and Health Research (MICHR) at the University of Michigan seeks to develop
a new postdoctoral T32 training program to prepare early-stage postdoctoral fellows for careers in translational
science and research. This two-year program emphasizes training in interdisciplinary team science that crosses
departments and disease states. Recruitment centers on non-clinically trained basic scientists from biomedical,
social, or data science disciplines, with particular focus on individuals from groups traditionally underrepresented
in translational science. We also endeavor to recruit doctoral-level allied health professionals (e.g., postdoctoral
individuals trained in nursing, pharmacy, physical therapy, and social work) that traditionally have had few
options for advanced translational research training. Five trainees are appointed per year. Each trainee has a
structured mentoring team that guides their professional and scientific development. This team includes Scientific
Mentors, a MICHR Advocate from a different field that serves as a neutral third party, and a Near-Peer Mentor.
Trainees and their mentoring team undergo didactic mentor training. Through the following Specific Aims, this
program works synergistically and purposefully with our K12 and predoctoral programs to fully integrate with
MICHR's mission to improve the lives of individuals and their communities through clinical and translational
research: 1) Provide postdoctoral trainees with precision preparation for a career in translational science,
including training on the fundamental characteristics of a translational scientist, participation in a Translational
Immersion Experience with patients, clinicians, and/or policymakers to improve their understanding of the
conditions they study, and through participation in the MICHR Career Development Studio, training in leadership
and practical skills required to obtain and manage a research program; 2) Strengthen and expand the
professional networks of postdoctoral trainees through networking and team science training, one-on-one
interviewing assignments, and frequent networking opportunities with leading content experts; and 3) Prepare
postdoctoral trainees to be versatile communicators with training in critical verbal and visual communication
skills, including communicating via social media and with the press, and participation in MICHR Writing Squads
and its K Writing Workshop to hone their written communication skills. Trainees and mentors also participate in
our new UM1 Inclusion, Diversity, Equity, and Accountable Leadership in Clinical and Translational Science
initiative (IDEAL-CTS). Trainees will have access to the MICHR Implementation ToolBox, a suite of educational
materials to support protocol implementation, and our M-COMPASS career development platform that provides
trainees with self-paced training modules for incorporation into individual development plans. Our expected
outcome is a postdoctoral T32 program that better prepares and equips trainees for long-term success in
conducting translational research and becoming strong leaders within diverse scientific communities that impact
human health.
Public Health Relevance Statement
Project Narrative
The Michigan Institute for Clinical and Health Research at the University of Michigan seeks to develop a new
postdoctoral T32 training program to prepare early-stage postdoctoral fellows for impactful careers in
translational science and research. Trainees receive personalized support for their training needs, multi-level
training to enhance their professional networks, communication and dissemination training for diverse audiences,
and training in diversity, health equity, and inclusion. The overall objective of this training program is to help form
the next generation of investigators that strive to improve the lives of individuals and their communities through
translational science and research.
National Center for Advancing Translational Sciences
CFDA Code
350
DUNS Number
073133571
UEI
GNJ7BBP73WE9
Project Start Date
01-December-2023
Project End Date
30-November-2028
Budget Start Date
01-December-2023
Budget End Date
30-November-2024
Project Funding Information for 2024
Total Funding
$446,734
Direct Costs
$416,420
Indirect Costs
$30,314
Year
Funding IC
FY Total Cost by IC
2024
National Center for Advancing Translational Sciences
$446,734
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1T32TR004764-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1T32TR004764-01
Patents
No Patents information available for 1T32TR004764-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1T32TR004764-01
Clinical Studies
No Clinical Studies information available for 1T32TR004764-01
News and More
Related News Releases
No news release information available for 1T32TR004764-01
History
No Historical information available for 1T32TR004764-01
Similar Projects
No Similar Projects information available for 1T32TR004764-01